Route 92 Medical, Inc. — SEC Form D Filing
Route 92 Medical, Inc. filed an SEC Form D on April 20, 2026, reporting $50.00M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- April 20, 2026
- Amount reported
- $50.00M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://www.route92medical.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Current approaches to neurointervention have limitations, including ineffective navigation through complex anatomy and high failure rates in reaching target locations.
Solution
Route 92 Medical overcomes these limitations with innovative catheter systems designed for superior performance in challenging anatomies.
Why now
There is a growing need for more effective neurovascular intervention solutions as existing methods are insufficient for optimal patient outcomes.
Verdict
Investors said yes to Route 92 Medical because they recognized the urgent need for improved neurointervention solutions, betting on its innovative catheter systems to address significant shortcomings in traditional methods. This narrative cleared because it presented a clear problem-solution fit in an underserved medical field, not solely because of the technical novelty of the product. However, limited upside exists due to the inherent risks in medical device markets and the challenge of proving efficacy amid existing competitive devices.
Source: SEC EDGAR Form D filing